Compensated HCV-related cirrhosis has poor prognosis

Article Abstract:

Researchers at the Hospital Saint-Antoine in Paris, France found that liver cirrhosis in patients with hepatitis C commonly progress to liver cancer and physiologic decompensation. Scientists remain baffled over the mortality rate of hepatitis C patients with liver cirrhosis. However, interferon therapy has been found to reduce the risk of liver cancer in hepatitis C patients. Of the 688 hepatitis C patients examined, 103 cases of cirrhosis were noted.

Complications and side effects, Development and progression, Hepatitis C, Liver cirrhosis

---

Study suggests hepatitis C can spread through saliva

Article Abstract:

A study conducted by researchers from Scotland found that hepatitis C virus (HCV) can also be transmitted through the saliva. Hepatitis C virus is commonly transmitted through blood transfusion and through intravenous drug use. Transmission of the HCV through the saliva may come from serum transudation or from the salivary glands. Signs of positive HCV in patients were dry mouth and reduced salivary output.

Communicable diseases, Disease transmission, Saliva, Hepatitis C virus

---

Similar abstracts:

• Abstracts: Costs should not exclude the poor from health care. The cost of AIDS. Health care: who should pay for what?
• Abstracts: Survey of advertising for nutritional supplements in health and bodybuilding magazines. Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning
• Abstracts: Novel mycobacterium identified. Rhinosporidiosis reported in U.S. AIDS patient. Rapid AIDS test undergoes New York field trial

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.